Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Podrobná bibliografie
Hlavní autoři:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Médium:	Článek
Jazyk:	Russian
Vydáno:	«FIRMA «SILICEA» LLC 2004-12-01
Edice:	Российский кардиологический журнал
Témata:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
On-line přístup:	https://russjcardiol.elpub.ru/jour/article/view/2326

Podobné jednotky

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
Autor: S. V. Nedogoda, a další
Vydáno: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
Autor: P. P. Tikhonov, a další
Vydáno: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
Autor: S. V. Nedogoda, a další
Vydáno: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
Autor: S. I. Drozdetsky, a další
Vydáno: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
Autor: A. P. Kondrakhin, a další
Vydáno: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
Autor: E. V. Eliseeva, a další
Vydáno: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
Autor: Y. R. Kasherininov, a další
Vydáno: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
Autor: Mehmet Burak Yalçın, a další
Vydáno: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
Autor: Osman Kukula, a další
Vydáno: (2024-02-01)

Main results of the Russian trial «ALTAIR»
Autor: E. V. Shlyakhto, a další
Vydáno: (2006-02-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
Autor: N. N. Nikitina, a další
Vydáno: (2015-12-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
Autor: Monique L Parkin, a další
Vydáno: (2016-11-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
Autor: V. Estato, a další
Vydáno: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
Autor: L. A. Khaisheva, a další
Vydáno: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
Autor: V. I. Makolkin
Vydáno: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
Autor: András Érszegi, a další
Vydáno: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
Autor: L. I. Markova, a další
Vydáno: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
Autor: V. A. Nevzorova, a další
Vydáno: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
Autor: I. E. Chazova, a další
Vydáno: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
Autor: I. N. Medvedev, a další
Vydáno: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
Autor: I. N. Medvedev, a další
Vydáno: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
Autor: I. N. Medvedev, a další
Vydáno: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
Autor: I. N. Medvedev, a další
Vydáno: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
Autor: A. P. Vasilyev, a další
Vydáno: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
Autor: A. N. Britov, a další
Vydáno: (2006-06-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
Autor: N. J. Gromnazky, a další
Vydáno: (2003-12-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
Autor: E. G. Ivanova, a další
Vydáno: (2023-04-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
Autor: G. N. Gorokhovskaya, a další
Vydáno: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
Autor: L. I. Abasova, a další
Vydáno: (2011-08-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
Autor: E. G. Ivanova, a další
Vydáno: (2022-07-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
Autor: M. M. Beraya, a další
Vydáno: (2007-02-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
Autor: A S Ryazanov, a další
Vydáno: (2003-03-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
Autor: E. V. Tishina, a další
Vydáno: (2011-06-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
Autor: M. M. Beraya, a další
Vydáno: (1970-01-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
Autor: V. V. Trusov, a další
Vydáno: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
Autor: Roman A. Yaskevich, a další
Vydáno: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
Autor: Roman A. Yaskevich, a další
Vydáno: (2022-06-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
Autor: I. S. Dzherieva, a další
Vydáno: (2015-12-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
Autor: Michał Łata, a další
Vydáno: (2025-01-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
Autor: O. A. Osipova, a další
Vydáno: (2022-10-01)